Dare Bioscience (DARE): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Dare Bioscience, Inc. (DARE) possesses a unique market advantage in gynecology, which will provide the company with pricing power upon product patenting. The trend in consensus EPS forecasts for the coming year visualizes these expectations, where 31.30 captures the current value of the indicator. Business growth relies on global drug development partnerships, while financial stability depends on pipeline execution and R&D cost control.

DARE: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Dare Bioscience 04.07.2022 - 12.11.2026

darebioscience.com - rincian analitis lan metrik utama (DARE)

- rega saham lan konsensus proyeksi valuasi:

Rega saham Dare Bioscience Inc.|DARE - Rata-rata rega prakiraan

- data kapitalisasi bursa:

Nilai pasar Daré Bioscience|DARE - Nilai Bisnis

- rincian nilai buku perusahaan:

Nilai Buku saben Saham Daré Bioscience|DARE - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku darebioscience.com|DARE - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Utang marang Ekuitas Dare Bioscience, Inc.|DARE - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Daré Bioscience|DARE - Utang kumulatif perusahaan|Utang marang nilai buku Daré Bioscience|DARE - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Daré Bioscience|Rasio cepet darebioscience.com

- informasi bathi lan kelipatan valuasi:

DARE - Asil keuangan resik|Bathi sing dikarepake Dare Bioscience, Inc.|DARE - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Dare Bioscience, Inc.|DARE - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Daré Bioscience|DARE - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Daré Bioscience|DARE - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan darebioscience.com|DARE - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Dare Bioscience, Inc.

Analisis fundamental perusahaan:Dare Bioscience Inc.

This indicator measures the expected earnings per share (EPS) growth, reflecting the analysts' consensus forecast regarding future business performance. Investors utilize the projected EPS growth rate to identify entry points and assess the asset's fair value. For Dare Bioscience, Inc. (DARE), this metric confirms market confidence in the commercialization of innovative women's health drugs and the success of clinical developments.

Analisis pesaing Dare Bioscience, Inc.

OGN (Organon Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep TherapeuticsMD Corp TXMD|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Palatin Technologies (PTN)